Skip to navigation Skip to content

X-linked hypophosphataemia (XLH) Program in Pharmaceutical Benefits Scheme (PBS) 012-22102650

Expand/Collapse all sectionsExpand all


This document outlines details of PBS-subsidised burosumab for patients with X-linked hypophosphataemia (XLH).

For information on how to process a PBS Authority, see Process Complex Authority Required Listings.

X-linked hypophosphataemia quick reference

Restrictions

Authority level and section

PA assessment

Processing system

Prescriber type

Prescriber self-serve

Initial

or

Continuing

Telephone

Electronic

S100:

burosumab

No

OPA

Must be treated by a:

  • paediatric endocrinologist
  • paediatric nephrologist
  • endocrinologist, or
  • nephrologist

Yes